Genomic Cancer Panel and Profiling Market Size is valued at USD 9.29 Bn in 2022 and is predicted to reach USD 18.69 Bn by the year 2031 at a 8.38% CAGR during the forecast period for 2023-2031.
Genomic cancer panels and profiling are cutting-edge method for early cancer detection that studies tumour genetic features before symptoms manifest. One of the main benefits of using these panels is the extensive genetic information they may give, which helps with early detection and creating individualized treatment programs. Genomic cancer panels and profiling can revolutionize cancer treatment, which is driving demand in the industry. Greater emphasis on early diagnosis as part of cancer patient therapy has contributed to the meteoric surge in the worldwide genomic cancer panel and profiling industry. The increasing demand for liquid biopsy tests is also driving industry growth. Furthermore, the rising cancer risk associated with people's changing lifestyles is another factor influencing the expansion of the industry.
However, the market growth is hampered by the lack of awareness criteria for the safety and health of the genomic cancer panel and profiling market and the product's inability to prevent fog in environments with dramatic temperature fluctuations or high genomic cancer panel and profiling, because the search for, creation of, and validation of biomarkers for use in cancer detection and prognosis incur substantial financial costs. There must be proof for the clinical field to use a newly developed candidate biomarker. Potential biomarkers are being found at a rate that is much faster than they can be validated.
The high prices of these tests make them difficult for patients to afford, which will likely limit their usage in cancer profiling. Strict restrictions imposed by the coronavirus outbreak, such as limiting contact and implementing lockdown precautions, have hindered regular cancer screenings. Counts of cancer have plummeted as a result of a considerable decrease in the false positives caused by COVID-19 infections, which include lung cancer and mild respiratory disease. COVID-19 may have an outsized impact on cancer patients compared to the overall population.
The genomic cancer panel and profiling market is segmented based on tissue testing, cancer panel type, cancer type, application, technology and end user. Based on tissue testing, the market is segmented into solid and liquid tissue testing. The market is segmented by cancer panel type into single-gene and multi-gene panels. As per the cancer type, the market is segmented into lung cancer, breast cancer, colon cancer, prostate cancer, and other cancers. According to application segment is categorised into clinical and research. By technology, the market is segmented into next-generation sequencing (NGS), polymerase chain reaction (PCR), fluorescence in-situ hybridization (FISH), immunohistochemistry (IHC), and others. By end user, the market is segmented into hospitals, clinical and diagnostic laboratories, and research and academic institutes.
The liquid tissue testing genomic cancer panel and profiling market is expected to hold a major global market share in 2022. liquid tissue testing is quickly becoming the method of choice in the global genomic cancer panel and profiling industry. This bodes well for the future of cancer research and treatment, as liquid sample testing is likely to supersede more conventional approaches.
Research and academic institutes comprise the bulk of genomic cancer panels and profiling because research institutes substantially facilitate the development of new cancer medicines and improve cancer diagnostics. Research institutions rely on gene panels and profiling tests for patient evaluations because they are leaders in clinical trials and drug development, especially in countries like the US, Germany, the UK, China, and India.
The North American genomic cancer panel and profiling market is estimated to lead with the maximum market revenue share in the near future. It can be attributed to because of the high concentration of major international corporations in the area, the rising cancer rate, and the widespread use of biomarkers in medication development. In addition, Asia Pacific is estimated to grow rapidly in the global genomic cancer panel and profiling market because different methods are being used in diagnostic centres, and more people are becoming aware of therapy procedures.
|
Report Attribute |
Specifications |
|
Market Size Value In 2022 |
USD 9.29 Bn |
|
Revenue Forecast In 2031 |
USD 18.69 Bn |
|
Growth Rate CAGR |
CAGR of 8.38 % from 2023 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Bn and CAGR from 2023 to 2031 |
|
Historic Year |
2019 to 2022 |
|
Forecast Year |
2023-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Tissue Testing, By Cancer Panel Type, By Cancer Type, By Application, By Technology, By End User |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea |
|
Competitive Landscape |
Agilent Technologies, Inc., ARUP Laboratories, Burning Rock DX, Caris Life Sciences, Thermo Fisher Scientific, Inc., Danaher Corporation (Integrated DNA Technologies, Inc.), Exact Sciences Corporation, F. Hoffmann-La Roche Ltd, Fulgent Genetics, Genecast Biotechnology Co., Ltd, Illumina, Inc., Invitae Corporation, Qiagen N.V., NeoGenomics, Inc., Sysmex Corporation, HTG Molecular Diagnostics, Inc., Predictive Oncology, Inc., NanoString Technologies, Inc., Guardant Health, Inc., Foundation Medicine, Genscript Biotech Corporation, Tempus Labs, Hologic, Inc., Others |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Genomic Cancer Panel and Profiling Market Snapshot
Chapter 4. Global Genomic Cancer Panel and Profiling Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Tissue Testing Estimates & Trend Analysis
5.1. By Tissue Testing, & Market Share, 2020 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Tissue Testing:
5.2.1. Solid Tissue Testing
5.2.2. Liquid Tissue Testing
Chapter 6. Market Segmentation 2: By Cancer Panel Type Estimates & Trend Analysis
6.1. By Cancer Panel Type & Market Share, 2020 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Cancer Panel Type:
6.2.1. Single-Gene Panel
6.2.2. Multi-Gene Panel
Chapter 7. Market Segmentation 3: By Cancer Type Estimates & Trend Analysis
7.1. By Cancer Type & Market Share, 2020 & 2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Cancer Type:
7.2.1. Lung Cancer
7.2.2. Breast Cancer
7.2.3. Colon Cancer
7.2.4. Prostate Cancer
7.2.5. Other Cancers
Chapter 8. Market Segmentation 4: By End-User Estimates & Trend Analysis
8.1. By End-User & Market Share, 2020 & 2031
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By End-User:
8.2.1. Hospitals
8.2.2. Clinical and Diagnostic Laboratories
8.2.3. Research and Academic Institutes
8.2.4. Other End Users
Chapter 9. Market Segmentation 5: By Technology Estimates & Trend Analysis
9.1. By Technology & Market Share, 2020 & 2031
9.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Technology:
9.2.1. Next-Generation Sequencing (NGS)
9.2.2. Polymerase Chain Reaction (PCR)
9.2.3. Fluorescence In-Situ Hybridization (FISH)
9.2.4. Immunohistochemistry (IHC)
9.2.5. Others
Chapter 10. Market Segmentation 6: By Application Estimates & Trend Analysis
10.1. By Application & Market Share, 2020 & 2031
10.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Application:
10.2.1. Clinical
10.2.2. Research
Chapter 11. Genomic Cancer Panel and Profiling Market Segmentation 7: Regional Estimates & Trend Analysis
11.1. North America
11.1.1. North America Genomic Cancer Panel and Profiling Market revenue in US$ Million estimates and forecasts By Tissue Testing, 2019-2031
11.1.2. North America Genomic Cancer Panel and Profiling Market revenue in US$ Million estimates and forecasts By Cancer Panel Type, 2019-2031
11.1.3. North America Genomic Cancer Panel and Profiling Market revenue in US$ Million estimates and forecasts By Cancer Type, 2019-2031
11.1.4. North America Genomic Cancer Panel and Profiling Market revenue in US$ Million estimates and forecasts By End-User, 2019-2031
11.1.5. North America Genomic Cancer Panel and Profiling Market revenue in US$ Million estimates and forecasts By Technology, 2019-2031
11.1.6. North America Genomic Cancer Panel and Profiling Market revenue in US$ Million estimates and forecasts By Application, 2019-2031
11.1.7. North America Genomic Cancer Panel and Profiling Market revenue in US$ Million estimates and forecasts by country, 2019-2031
11.2. Europe
11.2.1. Europe Genomic Cancer Panel and Profiling Market revenue in US$ Million By Tissue Testing, 2019-2031
11.2.2. Europe Genomic Cancer Panel and Profiling Market revenue in US$ Million By Cancer Panel Type, 2019-2031
11.2.3. Europe Genomic Cancer Panel and Profiling Market revenue in US$ Million By Cancer Type, 2019-2031
11.2.4. Europe Genomic Cancer Panel and Profiling Market revenue in US$ Million By End-User, 2019-2031
11.2.5. Europe Genomic Cancer Panel and Profiling Market revenue in US$ Million By Technology, 2019-2031
11.2.6. Europe Genomic Cancer Panel and Profiling Market revenue in US$ Million By Application, 2019-2031
11.2.7. Europe Genomic Cancer Panel and Profiling Market revenue in US$ Million by country, 2019-2031
11.3. Asia Pacific
11.3.1. Asia Pacific Genomic Cancer Panel and Profiling Market revenue in US$ Million By Tissue Testing, 2019-2031
11.3.2. Asia Pacific Genomic Cancer Panel and Profiling Market revenue in US$ Million By Cancer Panel Type, 2019-2031
11.3.3. Asia Pacific Genomic Cancer Panel and Profiling Market revenue in US$ Million By Cancer Type, 2019-2031
11.3.4. Asia Pacific Genomic Cancer Panel and Profiling Market revenue in US$ Million By End-User, 2019-2031
11.3.5. Asia Pacific Genomic Cancer Panel and Profiling Market revenue in US$ Million By Technology, 2019-2031
11.3.6. Asia Pacific Genomic Cancer Panel and Profiling Market revenue in US$ Million By Application, 2019-2031
11.3.7. Asia Pacific Genomic Cancer Panel and Profiling Market revenue in US$ Million by country, 2019-2031
11.4. Latin America
11.4.1. Latin America Genomic Cancer Panel and Profiling Market revenue in US$ Million By Tissue Testing, (US$ Million) 2019-2031
11.4.2. Latin America Genomic Cancer Panel and Profiling Market revenue in US$ Million By Cancer Panel Type, (US$ Million) 2019-2031
11.4.3. Latin America Genomic Cancer Panel and Profiling Market revenue in US$ Million By Cancer Type, (US$ Million) 2019-2031
11.4.4. Latin America Genomic Cancer Panel and Profiling Market revenue in US$ Million By End-User, (US$ Million) 2019-2031
11.4.5. Latin America Genomic Cancer Panel and Profiling Market revenue in US$ Million By Technology, (US$ Million) 2019-2031
11.4.6. Latin America Genomic Cancer Panel and Profiling Market revenue in US$ Million By Application, (US$ Million) 2019-2031
11.4.7. Latin America Genomic Cancer Panel and Profiling Market revenue in US$ Million by country, 2019-2031
11.5. Middle East & Africa
11.5.1. Middle East & Africa Genomic Cancer Panel and Profiling Market revenue in US$ Million By Tissue Testing, (US$ Million) 2019-2031
11.5.2. Middle East & Africa Genomic Cancer Panel and Profiling Market revenue in US$ Million By Cancer Panel Type, (US$ Million) 2019-2031
11.5.3. Middle East & Africa Genomic Cancer Panel and Profiling Market revenue in US$ Million By Cancer Type, (US$ Million) 2019-2031
11.5.4. Middle East & Africa Genomic Cancer Panel and Profiling Market revenue in US$ Million By End-User, (US$ Million) 2019-2031
11.5.5. Middle East & Africa Genomic Cancer Panel and Profiling Market revenue in US$ Million By Technology, (US$ Million) 2019-2031
11.5.6. Middle East & Africa Genomic Cancer Panel and Profiling Market revenue in US$ Million By Application, (US$ Million) 2019-2031
11.5.7. Middle East & Africa Genomic Cancer Panel and Profiling Market revenue in US$ Million by country, 2019-2031
Chapter 12. Competitive Landscape
12.1. Major Mergers and Acquisitions/Strategic Alliances
12.2. Company Profiles
12.2.1. Agilent Technologies, Inc.
12.2.2. ARUP Laboratories
12.2.3. Burning Rock DX
12.2.4. Caris Life Sciences
12.2.5. Thermo Fisher Scientific, Inc.
12.2.6. Danaher Corporation (Integrated DNA Technologies, Inc.)
12.2.7. Exact Sciences Corporation
12.2.8. F. Hoffmann-La Roche Ltd
12.2.9. Fulgent Genetics
12.2.10. Genecast Biotechnology Co., Ltd
12.2.11. Illumina, Inc.
12.2.12. Invitae Corporation
Genomic Cancer Panel and Profiling Market By Tissue Testing-
Genomic Cancer Panel and Profiling Market By Cancer Panel Type
Genomic Cancer Panel and Profiling Market By Cancer Type-
Genomic Cancer Panel and Profiling Market By Application-
Genomic Cancer Panel and Profiling Market By Technology-
Genomic Cancer Panel and Profiling Market By End User-
Genomic Cancer Panel and Profiling Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
